Newsroom

لندن--(BUSINESS WIRE)--تؤكد AM Best استمرار نظرتها المستقبلية المستقرة لأسواق التأمين في دول مجلس التعاون الخليجي.في تقريرجديد من Best ، بعنوان "توقعات قطاع السوق: عالم التأمين في دول مجلس التعاون الخليجي"، تشير AM Best إلى أنه رغم استمرار تعرض شركات التأمين في دول مجلس التعاون الخليجي لتأثيرات غير مباشرة من جراء الصراع في الشرق الأوسط، فإنَّ الأداء القوي ومستويات رأس المال القوية المعدَّلة وفقًا للمخاطر تُمكّن العديد منها من مواجهة التداعيات الجيوسياسية، رغم أنَّ استمرار الصراع لفترة طويلة في ا...

NEW YORK--(BUSINESS WIRE)--Bilt, the membership for where you live, today announced the expansion of its partnership with Qatar Airways Privilege Club – the loyalty program of Qatar Airways, the World's Best Airline as voted by Skytrax in 2025 for an unprecedented ninth time. Starting today, Bilt Members who hold an eligible Qatar Airways Privilege Club Credit Card can earn a total of 3 Avios per $1 spent on rent payments up to $50,000 per calendar year, processed through Bilt. This expansion e...

LAS VEGAS--(BUSINESS WIRE)--Seemplicity today announced its inclusion across four recent 2026 Gartner research reports covering Preemptive Exposure Management, Preemptive Exposure Assessment, and Application Security Posture Management (ASPM). As adversaries leverage AI to accelerate attack cycles, security teams are under growing pressure to move from passive visibility to active risk mobilization. In Seemplicity’s view, its inclusion across these four reports underscores the company's commitm...

NEW YORK--(BUSINESS WIRE)--On May 5, 2026, Myriad Genetics (NASDAQ: MYGN) reaffirmed adjusted EBITDA of $37 million to $49 million and adjusted gross margin of 68% to 69% for full-year 2026. Roughly three months later, the adjusted EBITDA range was suspended outright and MYGN shares dropped. If you held Myriad Genetics stock and lost money, you are encouraged to submit your loss information now. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (2...

SAN DIEGO, Calif.--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of investors who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”). The lawsuit alleges that Regeneron Pharmaceuticals misled investors regarding the viability and prospects of its Phase 3 Fianlimab-Libtayo clinical trial for patients with advanced melanoma. Invest...

ATLANTA--(BUSINESS WIRE)--As hospitals continue looking for new ways to elevate the patient experience, Morrison Healthcare introduces its new Maternity Experience Program: a hospitality-driven approach designed to help hospitals create more personalized, memorable moments for maternity patients and their families. For many families, the maternity journey is one of life’s most meaningful milestones. Morrison Healthcare’s Maternity Experience Program transforms traditional foodservice into an ex...

NEW YORK--(BUSINESS WIRE)--A guidance gap of roughly $400 million to $500 million in sales, and up to $0.35 per share in earnings, is what AGCO Corporation (NYSE: AGCO) investors were handed on July 30, 2026, when the Company reduced its full-year 2026 outlook alongside second-quarter results and the stock declined. If you suffered a loss on your AGCO investment, you are encouraged to submit your information for a free case evaluation. You may also contact Joseph E. Levi, Esq. via email at jlev...

EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Sidd...

SANTA CLARA, Californie--(BUSINESS WIRE)--Conférence Future of Memory and Storage (FMS) : Kioxia Corporation, une filiale de Kioxia Holdings Corporation (TOKYO : 285A) et de Sandisk Corporation (Nasdaq : SNDK), a présenté aujourd'hui sa technologie de mémoire flash 3D Quad-Level-Cell (QLC) de nouvelle génération. Cette mémoire offre une augmentation de la densité de bits de 60 % par rapport à sa 8e génération, dépassant 37 Gb/mm² et établissant la norme de référence en matière1 de densité de bi...

SANTA CLARA, Kalif.--(BUSINESS WIRE)--Future of Memory and Storage Conference (FMS) – Kioxia Corporation, eine Tochtergesellschaft der Kioxia Holdings Corporation (TOKYO: 285A) und der SanDisk Corporation (Nasdaq: SNDK), hat heute ihre 3D-Flash-Speichertechnologie der nächsten Generation mit Quad-Level-Cell (QLC) vorgestellt, die im Vergleich zur 8. Generation eine um bis zu 60 % höhere Bitdichte bietet, 37 Gb/mm² übersteigt und damit einen neuen Branchenmaßstab setzt1 und zwar in Bezug auf Bit...